Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inadvertent lymphoscintigraphy?

I Boxen

    Clinical Nuclear Medicine
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Bone imaging agent Tc-99m imidodiphosphate (Tc-99m IDP) shows uptake in lymph nodes. This finding suggests Tc-99m IDP may be a valuable tool for lymphoscintigraphy, enhancing diagnostic capabilities.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A prospective study of factors predicting clinically occult spinal cord compression in patients with metastatic prostate carcinoma.

    Cancer·2001
    Same author

    Photodegraded nifedipine augmented tumor cell uptake of gallium.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2000
    Same author

    Sentinel node detection and definition may depend on the imaging agent and timing.

    Clinical nuclear medicine·1999
    Same author

    Simulation of renal function by tumor and its effect on the calculated glomerular filtration rate.

    Clinical nuclear medicine·1999
    Same author

    Gallium accumulation in marrow lymphocytes.

    Clinical nuclear medicine·1999
    Same author

    Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug-resistant breast tumor cells.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·1996
    Same journal

    Intense Incidental F-18 DOPA Uptake in Low-grade Prostate Adenocarcinoma: A Potential Diagnostic Pitfall.

    Clinical nuclear medicine·2026
    Same journal

    A Prospective Head-to-Head Comparison of HER2-Targeted and 18F-FDG PET/CT for Detecting Axillary Lymph Node Metastases Among Newly Diagnosed HER2-Positive and HER2-Low Breast Cancer.

    Clinical nuclear medicine·2026
    Same journal

    Epileptogenic Brain Metastasis Early Positive on 18FDG PET/CT Compared to MRI.

    Clinical nuclear medicine·2026
    Same journal

    Dural Manifestation of Langerhans Cell Histiocytosis​: Multimodality Imaging Approach.

    Clinical nuclear medicine·2026
    Same journal

    Malignant Perivascular Epithelioid Cell Tumor (PEComa) of Left Adrenal Gland With Extensive Intravenous Tumor Thrombi: 18F-FDG PET/CT Findings.

    Clinical nuclear medicine·2026
    Same journal

    18F-MFBG Uptake From Multiple Focal "Hot Spots" to Superscan in a Pediatric Patient With High-risk Neuroblastoma.

    Clinical nuclear medicine·2026
    See all related articles

    Area of Science:

    • Nuclear medicine
    • Radiopharmacology
    • Medical imaging

    Background:

    • Bone imaging agents are crucial for visualizing skeletal structures.
    • Lymph node imaging (lymphoscintigraphy) aids in diagnosing various conditions, including lymphedema and metastatic spread.
    • Technetium-99m imidodiphosphate (Tc-99m IDP) is a well-established bone-seeking radiotracer.

    Purpose of the Study:

    • To present evidence of lymph node uptake for the bone imaging agent Tc-99m imidodiphosphate (Tc-99m IDP).
    • To explore the potential utility of Tc-99m IDP in lymphoscintigraphy.

    Main Methods:

    • Case series presentation of patients undergoing bone scintigraphy.
    • Analysis of imaging data to identify radiotracer accumulation in lymph node regions.
    • Qualitative assessment of Tc-99m IDP distribution patterns.

    Related Experiment Videos

    Main Results:

    • Observed instances of Tc-99m IDP accumulation in lymph nodes were documented.
    • The distribution patterns suggest specific lymph node targeting by the agent.
    • These findings represent potential lymph node uptake of Tc-99m IDP.

    Conclusions:

    • The bone imaging agent Tc-99m imidodiphosphate (Tc-99m IDP) demonstrates uptake in lymph nodes.
    • Tc-99m IDP may serve as a novel agent for lymphoscintigraphy.
    • Further research is warranted to confirm and characterize this phenomenon for clinical application.